Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Hepatology (Baltimore, Md.)|November 21, 2013
The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver diseaseVictoria L Gadd, Richard Skoien, Elizabeth E Powell, et al.
Plos One|March 18, 2015
Ascites bacterial burden and immune cell profile are associated with poor clinical outcomes in the absence of overt infectionKevin J Fagan, Geraint B Rogers, Michelle Melino, et al.
Plos One|November 19, 2016
Multiplex Serum Protein Analysis Identifies Novel Biomarkers of Advanced Fibrosis in Patients with Chronic Liver Disease with the Potential to Improve Diagnostic Accuracy of Established BiomarkersKatharine M Irvine, Leesa F Wockner, Isabell Hoffmann, et al.
BMC Gastroenterology|June 3, 2014
Diagnostic sensitivity of carbohydrate deficient transferrin in heavy drinkersKevin J Fagan, Katharine M Irvine, Brett C McWhinney, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 25, 2015
The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver diseaseKatharine M Irvine, Leesa F Wockner, Mihir Shanker, et al.
Alcoholism, Clinical and Experimental Research|July 24, 2013
BMI but not stage or etiology of nonalcoholic liver disease affects the diagnostic utility of carbohydrate-deficient transferrinKevin J Fagan, Katharine M Irvine, Brett C McWhinney, et al.
JCI Insight|July 27, 2018
Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genesDivya Ramnath, Katharine M Irvine, Samuel W Lukowski, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 16, 2014
ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activityKevin J Fagan, Carel J Pretorius, Leigh U Horsfall, et al.
Pageof 1